^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Cholangiocarcinoma |
| Drug: | gemcitabine (DNA synthesis inhibitor) + albumin-bound paclitaxel (Bcl2 inhibitor, Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Primary Treatment for Unresectable and Metastatic Disease: Other Recommended Regimens...Gemcitabine + albumin-bound paclitaxel (cholangiocarcinoma only).
